BCMA
-
Breaking News! Legend Biotech’s CAR-T product “Ciltacabtagene Autoleucel” has been approved in China
Warmest congratulations to Legend Bio and JnJ!
-
Exchanging a CAR-T therapy for 18% of the shares, the decision-making of Innovent Biologics
All comments are highly welcome!
-
一款CAR-T 换 18%股份，信达生物的取舍
关注药时代，一起洞察行业，共创未来！
-
首款抗BCMA药物获批，葛兰素史克强势回归抗肿瘤赛场
⬆️ 欢迎参加2020中国NASH大会！ 2020年8月6日，葛兰素史克（Glaxo Smith Kline，GSK）宣布其多发性骨髓瘤药物贝兰他单抗莫福汀（bela…
